PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2052282
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2052282
Elastomeric Infusion Pumps Market is estimated to be valued at USD 2,359.0 Mn in 2026 and is expected to reach USD 2,618.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2,359 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.60% | 2033 Value Projection: | USD 2,618.8 Mn |
Elastomeric infusion pumps are non-electronic medication pumps also called as balloon pumps which are used for infusion of analgesics, chemotherapy drugs, local anesthetics, antibiotics and other type of medications. Elastomeric infusion pumps are single use medical devices used for drug infusion. The process of infusion is carried out with the help of consistent pressure created in the elastomeric layer present in the pump which is controlled with the help of flow restrictors located in the elastomeric reservoir.
Increase in the prevalence of chronic diseases like cancer is expected to propel growth of market. For instance, according to factsheet published by World Health Organization (WHO) on 3 February, 2022, nearly 10 million deaths, or nearly one in six deaths were caused by cancer in 2021, making it the leading cause of death globally. Breast, lung, colon, rectum, and prostate cancers are the most prevalent types of cancer. In addition, according to WHO, each year, approximately 400,000 children develop cancer. Thus due to prevalence of cancer the global elastomeric infusion pumps market is expected grow over the forecast period.
Moreover, elastomeric infusion pumps are cheaper and have fewer adverse effects compared to electronic pumps, which increases their adoption in ambulatory chemotherapy infusion centers. Moreover, as elastomeric infusion pumps do not require electricity to operate, the risk for free flow of medication to patients is eliminated. Such advantages of elastomeric infusion pumps over their electric counterparts is also expected to boost growth of market.